A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer

SIMPLE SUMMARY: Patients with high-risk prostate cancer are usually treated with combination of radiotherapy and androgen deprivation therapy. However, there has been long strides of advancements in the domain of radiotherapy and systemic therapy in the last decade. Similarly, there has been signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, Laura, Roy, Soumyajit, Morgan, Scott, Malone, Shawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428221/
https://www.ncbi.nlm.nih.gov/pubmed/34503067
http://dx.doi.org/10.3390/cancers13174257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428221/
https://www.ncbi.nlm.nih.gov/pubmed/34503067
http://dx.doi.org/10.3390/cancers13174257

Ejemplares similares